Clinical Trial Update: Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update covers long-term follow-up of RGX-314 in neovascular age-related macular degeneration, including a fellow-eye substudy, spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• RGX-314

Snippet

Sponsor: AbbVie | Conditions: Neovascular Age-related Macular Degeneration, Wet Macular Degeneration | Phase 2 | Status: ENROLLING_BY_INVITATION